Loading...

HRP Goat anti-mouse IgG (minimal x-reactivity) Antibody

Pricing & Availability
Clone
Poly4053 (See other available formats)
Regulatory Status
RUO
Isotype
Goat Polyclonal IgG
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
405306 500 µL 113€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

This polyclonal goat anti-mouse IgG antibody reacts with the heavy chains of mouse IgG and with the light (kappa and lambda) chains common to most mouse immunoglobulins. No cross-reactivity has been detected against non-immunoglobulin serum proteins. This antibody has been solid-phase absorbed to ensure minimal cross-reaction with rat, human, bovine, horse, and rabbit immunoglobulins, but it may have minimal cross-reactivity with other subclasses of mouse immunoglobulins.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Polyclonal
Host Species
Goat
Formulation
Aqueous buffered solution containing a carrier protein and preservatives.
Preparation
The polyclonal antibody was purified from goat antiserum by mouse immunoglobulin affinity chromatography.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

To obtain lot-specific expiration date, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)

This product has a shelf-life of 12 months or less. Please use our Expiration Lookup Tool to verify the expiration date of your lot of product
Application

ELISA - Quality tested
WB, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by ELISA assay. Do not use this product beyond the expiration date. For ELISA or Western blot analysis, the reagent should be titrated between 1:2,000 - 1:5,000 to determine optimal conditions. For IHC on tissue sections, the reagent should be titrated between 1:500 - 1:2000 to determine optimal conditions. It is recommended that the reagent be titrated for optimal performance for each application. Avoid using diluent solutions containg sodium azide. Sodium azide is an inhibitor of horseradish peroxidase.

Application Notes

This polyclonal goat anti-mouse IgG antibody is useful for capture or detection of mouse IgG in ELISA.

Application References
  1. Scotta C, et al. 2008. J Immunol. 181:1025-33. PubMed
  2. Gao X, et al. 2014. Cell Mol Neurobiol. 34:257-68 (ICC)
  3. Winters T, et al. 2014. EMBO J. 33:1256-70.
Product Citations
  1. Ortega-Prieto AM, et al. 2018. Nat Commun. 9:682. PubMed
  2. Miyamoto M, et al. 2018. Oncol Lett. 15:4005. PubMed
  3. Chen G, et al. 2018. Front Immunol. 9:549. PubMed
  4. Omer S et al. 2018. eLife. 7 pii: e36745. PubMed
  5. Wang C, et al. 2019. PLoS Pathog. 15:e1007938. PubMed
  6. Chung KP, et al. 2019. Nat Commun. 10:3390. PubMed
  7. Chiang CF, et al. 2019. Sci Rep. 9:12448. PubMed
  8. Martinov T, et al. 2019. J Immunol. 203:844. PubMed
  9. Ventura E, et al. 2018. J Cell Sci. 131. PubMed
  10. Biering SB et al. 2017. Cell host & microbe. 22(1):74-85 . PubMed
  11. Prakash P, et al. 2019. Methods Protoc. 2:48. PubMed
  12. Zhang B, et al. 2020. J Exp Med. 217:e20182365. PubMed
  13. Jin SW, et al. 2019. Cell Rep. 29:1449. PubMed
  14. Parks KR, et al. 2019. Cell Rep. 29:3060. PubMed
  15. Hoffmann D, et al. 2020. Int J Tryptophan Res. 12:1178646919891736. PubMed
  16. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  17. Wu YH, et al. 2020. Mol Med Rep. 21:851. PubMed
  18. Nanna AR, et al. 2020. Nucleic Acids Res. 48:5281. PubMed
  19. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  20. Frank N, et al. 2011. Cancer Res. 71:1474. PubMed
  21. Hwang S, et al. 2012. Proc Natl Acad Sci U S A. 110:276. PubMed
  22. Horton N, et al. 2013. PLoS One. 8:e59552. PubMed
  23. Hsing C, et al. 2008. Cytokine. 44:221. PubMed
  24. Yan L, et al. 2014. Clin Vaccine Immunol. 21:1206. PubMed
  25. Copp J, et al. 2014. Proc Natl Acad Sci U S A. 111:13481. PubMed
  26. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  27. Shkoporov A, et al. 2015. FEMS Microbiol Lett. 362:83. PubMed
  28. Nishigami Y, et al. 2016. Sci Rep. 6:18964. PubMed
  29. Sertorio M, et al. 2016. J Immunol. 196: 2986-2994. PubMed
  30. Spanier J, et al. 2016. Nat Commun. 7:11804. PubMed
  31. Vrieling M, et al. 2016. Sci Rep. 6:37759. PubMed
  32. Hoffmann D, et al. 2020. Cancer Immunol Res. 8:19. PubMed
  33. Ram AK, et al. 2020. World J Gastroenterol. 26:7131. PubMed
  34. Lee K, et al. 2020. Biology (Basel). 9:00. PubMed
  35. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  36. Hsu HW, et al. 2020. Development. 147:00:00. PubMed
  37. Furlong K, et al. 2020. J Virol. 94:00:00. PubMed
  38. Boyt DT, et al. 2020. J R Soc Interface. 17:20190815. PubMed
  39. Christin JR, et al. 2020. Cell Reports. 31(10):107742. PubMed
  40. Uka R, et al. 2020. Oncogene. 39:4132. PubMed
  41. Gupta A, et al. 2020. J Biol Chem. 295:2057. PubMed
  42. Song E, et al. 2021. J Exp Med. 218:00:00. PubMed
  43. Yaguchi J, et al. 2021. BMC Biology. 19(1):64. PubMed
  44. Lin YR, et al. 2020. Immunity. 53(4):840-851.e6. PubMed
  45. Seydoux E, et al. 2021. Cell Reports. 35(5):109084. PubMed
  46. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  47. Sharma A, et al. 2021. Traffic. 22:332. PubMed
  48. Israelow B, et al. 2020. bioRxiv. . PubMed
  49. Powell AE, et al. 2020. bioRxiv. . PubMed
  50. Song E, et al. 2020. bioRxiv. . PubMed
  51. Zhang S, et al. 2021. Front Oncol. 585457:11. PubMed
  52. Kiianitsa K, et al. 2020. DNA Repair (Amst). 96:102977. PubMed
  53. Powell AE, et al. 2021. ACS Cent Sci. 7:183. PubMed
  54. Ma Y, et al. 2021. Sci Rep. 11:13471. PubMed
  55. Gopinath A, et al. 2021. NPJ Parkinsons Dis. 7:62. PubMed
  56. Caglar Beker M, et al. 2020. Turk J Med Sci. Online ahead of print. PubMed
  57. Baba T, et al. 2021. Cell Death Dis. 12:322. PubMed
  58. Harbour JC, et al. 2021. J Immunol. 206:2596. PubMed
  59. Tao L, et al. 2021. Light Sci Appl. 10:179. PubMed
  60. Pibuel MA, et al. 2021. Cell Death Discov. 7:280. PubMed
  61. Liang YH, et al. 2021. J Biomed Sci. 28:75. PubMed
  62. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  63. Klaessens S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  64. Mamedov T, et al. 2021. Front Plant Sci. 12:742875. PubMed
  65. Zhang Q, et al. 2021. Front Cell Infect Microbiol. 11:766922. PubMed
  66. Khan AA, et al. 2022. Bioconjug Chem. . PubMed
  67. Huang WC, et al. 2022. Sci Rep. 12:3612. PubMed
  68. Harbuzariu A, et al. 2022. iScience. 25:104407. PubMed
  69. Fang Z, et al. 2022. Nat Commun. 13:3250. PubMed
  70. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  71. Song E, et al. 2021. Cell Rep Med. 2:100288. PubMed
  72. Lun Y, et al. 2021. J Immunol. 206:2819. PubMed
  73. Wang K, et al. 2021. EMBO Rep. 22:e52205. PubMed
  74. Rutkauskaite J, et al. 2022. iScience. 25:104515. PubMed
  75. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
  76. Rodems TS, et al. 2022. Commun Biol. 5:897. PubMed
  77. Powell AE, et al. 2022. Front Immunol. 13:942897. PubMed
  78. Lee SH, et al. 2022. Nat Commun. 13:5461. PubMed
  79. Nitiss JL, et al. 2021. Curr Protoc. 1:e250. PubMed
  80. Han G, et al. 2022. Ann Transl Med. 10:1134. PubMed
  81. Lužnik Marzidovšek Z, et al. 2022. Am J Pathol. 192:270. PubMed
  82. Wright A, et al. 2022. Int J Mol Sci. 23: . PubMed
  83. Hsu J, et al. 2022. J Biol Chem. 299:102848. PubMed
  84. Wang D, et al. 2023. J Exp Clin Cancer Res. 42:26. PubMed
  85. Deich C, et al. 2023. J Biol Eng. 17:4. PubMed
  86. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  87. Lo NTN, et al. 2022. J Virol. 96:e0066122. PubMed
  88. Knudsen ML, et al. 2022. iScience. 25:105473. PubMed
  89. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  90. Apte S, et al. 2023. Sci Adv. 9:eade1851. PubMed
  91. Weidenbacher PA, et al. 2023. Nat Commun. 14:2149. PubMed
  92. Kaur K, et al. 2023. Front Immunol. 14:1132807. PubMed
  93. Pibuel MA, et al. 2023. Sci Rep. 13:9356. PubMed
RRID
AB_315009 (BioLegend Cat. No. 405306)
Go To Top Version: 6    Revision Date: 12-12-2022

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account